DSM-Firmenich AG (DSFIY) Stock Price & Analysis
DSM-Firmenich AG (DSFIY) closed at USD 12.3 on Thursday, October 22, 2026, up 0.74% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 12.21; the Oct 22, 2026 session ranged USD 12.14–12.3 on volume of 1,767 shares. Market capitalization is $30.06B, with a 52-week range of USD 6.4–12.36 (OQX). Source: Nexqual, retrieved October 23, 2026 at 16:42 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DSFIY.md
Key facts (DSFIY)
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 11.34 (range 11.34–11.34).
- Total return with dividends: 1Y +44.8% vs S&P 500 +14.6%; 5Y +1.1% vs S&P 500 +77.3%.
Analysts (DSFIY)
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 11.34 (low 11.34, high 11.34).
Total return (dividends reinvested) (DSFIY)
| 1Y (from 2025-10-23) | 5Y (from 2024-08-12) | |
|---|---|---|
| Total return | +44.8% | +1.1% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | +44.9% | +0.5% |
| Volatility (annualized) | 33.6% | 31.2% |
| Max drawdown | -27.0% (Oct 2025→Mar 2026) | -50.1% (Sep 2024→Mar 2026) |
DSFIY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $2.37B | — |
| Next quarter (ends Dec 2026) | — | — | — | $2.28B | — |
| Current fiscal year (ends Dec 2026) | $0.37 | $0.35 | +5.7% | $9.30B | 1 |
| Next fiscal year (ends Dec 2027) | $0.42 | $0.40 | +5.0% | $9.76B | 1 |
Key Statistics (as of October 23, 2026 at 16:42 UTC)
| Price | USD 12.3 |
|---|---|
| Change | ▲ 0.74% (up) |
| Previous Close | USD 12.21 |
| Open | USD 12.14 |
| Day Range | USD 12.14 – 12.3 |
| 52-Week Range | USD 6.4 – 12.36 |
| Volume | 1,767 shares |
| Market Cap | $30.06B |
| Exchange | OQX |
Technical Analysis (DSFIY)
Nexqual's technical model rates DSFIY "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 16:42 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.69 (neutral) |
| vs SMA50 | Above (USD 10.96) |
| MACD | 0.39 (positive) |
Analyst Ratings (DSFIY)
Wall Street analysts rate DSFIY "Hold" based on 1 analysts, with a mean price target of USD 11.34 (range USD 11.34–11.34), per Nexqual as of October 23, 2026 at 16:42 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 11.34 |
| High Target | USD 11.34 |
| Low Target | USD 11.34 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (DSFIY)
| Revenue Estimate | $2.37B |
|---|
Source: Nexqual, October 23, 2026 at 16:42 UTC.
Financials & Fundamentals (DSFIY)
| Total Revenue | $9.05B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.50% |
| Gross Margin | +39.18% |
| Operating Margin | +7.93% |
| Profit Margin | -15.23% |
| ROE | +1.87% |
| Debt / Equity | 0.38 |
| Current Ratio | 1.75 |
| Total Cash | $2.31B |
| Total Debt | $6.77B |
Source: Nexqual, October 23, 2026 at 16:42 UTC.
Financial Health Score (DSFIY)
Nexqual rates DSM-Firmenich AG's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:42 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 39%, operating 8% (last 12 months) |
| Balance Sheet | Solid — EUR 2.31B cash vs EUR 6.77B debt |
| Cash Flow | Solid — Operating cash flow EUR 1.65B (TTM) |
| Efficiency | Weak — ROE 2%, ROA 1.2% |
Ownership (DSFIY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.30% |
| Shares Outstanding | 2.44B |
| Float | 2.25B |
Source: Nexqual, October 23, 2026 at 16:42 UTC.
Leadership (DSFIY)
DSM-Firmenich AG is led by Dimitri de Vreeze, Chief Executive Officer, per Nexqual as of October 23, 2026 at 16:42 UTC.
| Chief Executive Officer | Dimitri de Vreeze |
|---|---|
| Chief Financial Officer | Ralf Schmeitz |
| BU President of Perfumery & Beauty and COO | Emmanuel Butstraen |
| Senior Vice President of Investor Relations | Dave Huizing |
| Chief Strategy, M & A and Transformation Officer | Philip Eykerman |
Major Backers & Investors (DSFIY)
Notable institutional backers of DSM-Firmenich AG include Aristotle Capital Management, LLC, according to Nexqual as of October 23, 2026 at 16:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Aristotle Capital Management, LLC | 0.24% |
Source: Nexqual, October 23, 2026 at 16:42 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PPG | PPG Industries, Inc. | USD 110.72 | ▼ 2.1% |
| IFF | International Flavors & Fragran | USD 93.91 | ▲ 0.09% |
| LYB | LyondellBasell Industries NV | USD 66.4 | ▲ 1.58% |
| DD | DuPont de Nemours, Inc. | USD 135.99 | ▲ 0.66% |
| SQM | Sociedad Quimica y Minera S.A. | USD 56.53 | ▲ 0.28% |
| APD | Air Products and Chemicals, Inc | USD 307.52 | ▼ 0.23% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:42 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt